News related to Alkeran Injection (Melphalan) and/or conditions it is approved for
melphalan-oral, Alkeran
Source: MedicineNet Amyloidosis Specialty [2005.03.02]
Title: melphalan-oral, Alkeran
Category: Medications
Created: 3/2/2005
Last Editorial Review: 3/2/2005
Delcath Systems Granted Orphan-Drug Designations For Cutaneous And Ocular Melanoma
Source: Eye Health / Blindness News From Medical News Today [2008.11.19]
Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary liver cancer treatment for melanoma metastatic to the liver, announced that the United States Food and Drug Administration ("FDA") granted to Delcath two orphan-drug applications for the drug melphalan. Delcath was granted designations of the drug melphalan for the treatment of patients with cutaneous as well as ocular melanoma.
Multiple Myeloma
Source: MedicineNet Essential Mixed Cryoglobulinemia Specialty [2006.08.22]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/22/2006
|
